Úsek pro vědu a výzkum

Ing. Michaela Dostálová Merkerová, Ph.D.

odborný pracovník v laboratorních metodách

Tel: +420 221 977 369
Email: Michaela.Merkerova@uhkt.cz

Impaktované publikace

[21]

Šestáková, Š.; Krejčík, Z.; Folta, A.; Cerovská, E.; Šálek, C.; Dostálová Merkerová, M.; Pecherková, P.; Ráčil, Z.; Mayer, J.; Cetkovský, P.; Remešová, H.

DNA methylation and hydroxymethylation patterns in acute myeloid leukemia patients with mutations in DNMT3A and IDH1/2 and their combinations

[rok vydání 2019, impact factor 3.436 ]

[22]

Sram, R.J.; Binkova, B.; Dostal, M.; Merkerova-Dostalova, M.; Libalova, H.; Milcova, A.; Rossner, P.; Rossnerova, A.; Schmuczerova, J.; Svecova, V.; Topinka, J.; Votavova, H.

Health impact of air pollution to children

[rok vydání 2013, impact factor 3.276 ]

[23]

Bruchova, H.; Vasikova, A.; Merkerova, M.; Milcova, A.; Topinka, J.; Balascak, I.; Pastorkova, A.; Sram, RJ.; Brdicka, R.

Effect of maternal tobacco smoke exposure on the placental transcriptome.

[rok vydání 2010, impact factor 2.985]

[24]

Krejcik, Z.; Belickova, M.; Hrustincova, A.; Votavova, H.; Jonasova, A.; Cermak, J.; Dyr, J.E.; Merkerova, M.D.

MicroRNA profiles as predictive markers of response to azacitidine therapy in myelodysplastic syndromes and acute myeloid leukemia

[rok vydání 2018, impact factor 2.859 ]

[25]

Bystricka, D.; Sarova, I.; Zemanova, Z.; Brezinova, J.; Lizcova, L.; Izakova, S.; Dostalova-Merkerova, M.; Krejcik, Z.; Siskova, M.; Jonasova, A.; Neuwirtova, R.; Cerna, O.; Cermak, J.; Michalova, K.

Recurrent chromosomal breakpoints in patients with myelodysplastic syndromes and complex karyotype versus fragile sites

[rok vydání 2011, impact factor 2.764 ]

[26]

Zemanova, Z.; Michalova, K.; Buryova, H.; Brezinova, J.; Kostylkova, K.; Bystricka, D.; Novakova, M.; Sarova, I.; Izakova, S.; Lizcova, L.; Ransdorfova, S.; Krejcik, Z.; Dostalova Merkerova, M.; Dohnalova, A.; Siskova, M.; Jonasova, A.; Neuwirtova, R.; Cermak, J.

Involvement of deleted chromosome 5 in complex chromosomal aberrations in newly diagnosed myelodysplastic syndromes (MDS) is correlated with extremely adverse prognosis

[rok vydání 2014, impact factor 2.692 ]

[27]

Valka, J.; Vesela, J.; Votavova, H.; Dostalova-Merkerova, M.; Horakova, Z.; Campr, V.; Brezinova, J.; Zemanova, Z.; Jonasova, A.; Cermak, J.; Belickova, M.

Differential expression of homologous recombination DNA repair genes in the early and advanced stages of myelodysplastic syndrome

[rok vydání 2017, impact factor 2.595 ]

[28]

Merkerova, M.; Bruchova, H.; Brdicka, R.

Expression analysis of PCNA gene in chronic myelogenous leukemia : combined application of siRNA silencing and expression arrays

[rok vydání 2007, impact factor 2.561]

[29]

Dostalova Merkerova, M.; Krejcik, Z.; Belickova, M.; Hrustincova, A.; Klema, J.; Stara, E.; Zemanova, Z.; Michalova, K.; Cermak, J.; Jonasova, A.

Genome-wide miRNA profiling in myelodysplastic syndrome with del(5q) treated with lenalidomide

[rok vydání 2014, impact factor 2.544 ]

[30]

Votavova, H.; Merkerova, M.D.; Krejcik, Z.; Fejglova, K.; Vasikova, A.; Pastorkova, A.; Tabashidze, N.; Topinka, J.; Balascak, I.; Sram, R.J.; Brdicka, R.

Deregulation of gene expression induced by environmental tobacco smoke exposure in pregnancy

[rok vydání 2012, impact factor 2.477 ]

[31]

Merkerova, M.; Vasikova, A.; Bruchova, H.; Libalova, H.; Topinka, J.; Balascak, I.; Sram, R.J.; Brdicka, R.

Differential gene expression in umbilical cord blood and maternal peripheral blood

[rok vydání 2009, impact factor 2.345]

[32]

Krejčík, Z.; Beličková, M.; Hruštincová, A.; Kléma, J.; Zemanová, Z.; Michalová, K.; Čermák, J.; Jonášová, A.; Dostálová Merkerová, M.

Aberrant expression of the microRNA cluster in 14q32 is associated with del(5q) myelodysplastic syndrome and lenalidomide treatment

[rok vydání 2015, impact factor 2.333 ]

[33]

Merkerová, M.; Dostál, J.; Hradilek, M.; Pichová, I.; Hrušková-Heidingsfeldová, O.

Cloning and characterization of Sapp2p, the second aspartic proteinase isoenzyme from Candida parapsilosis

[rok vydání 2007, impact factor 2.274]

[34]

Merkerova, M.; Belickova, M.; Bruchova, H.

Differential expression of microRNAs in hematopoietic cell lineages

[rok vydání 2008, impact factor 2.237]

[35]

Valka, J.; Vesela, J.; Votavova, H.; Dostalova-Merkerova, M.; Urbanova, Z.; Jonasova, A.; Cermak, J.; Belickova, M.

Genetic variant screening of DNA repair genes in myelodysplastic syndrome identifies a novel mutation in the XRCC2 gene

[rok vydání 2019, impact factor 1.967 ]

[36]

Dostalova Merkerova, M.; Hrustincova, A.; Krejcik, Z.; Votavova, H.; Ratajova, E.; Cermak, J.; Belickova, M.

Microarray profiling defines circulating microRNAs associated with myelodysplastic syndromes

[rok vydání 2017, impact factor 1.696 ]

[37]

Belickova, M.; Cermak, J.; Dostalova Merkerova, M.; Vesela, J.; Krejcik, Z.; Cechova, E.; Zemanova, Z.; Michalova, K.; Votavova, H.; Caniga, M.; Neuwirtova, R.; Jonasova, A.

Changes associated with lenalidomide treatment in the gene expression profiles of patients with del(5q)

[rok vydání 2012, impact factor 1.667 ]

[38]

Belickova, M.; Dostalova Merkerova, M.; Votavova, H.; Valka, J.; Vesela, J.; Pejsova, B.; Hajkova, H.; Klema, J.; Cermak, J.; Jonasova, A.

Up-regulation of ribosomal genes is associated with a poor response to azacitidine in myelodysplasia and related neoplasms

[rok vydání 2016, impact factor 1.610 ]

[39]

Merkerova, M.; Bruchova, H.; Kracmarova, A.; Klamova, H.; Brdicka, R.

Bmi-1 over-expression plays a secondary role in chronic myeloid leukemia transformation

[rok vydání 2007, impact factor 1.512]

[40]

Dostál, J.; Merkerová, M.; Vinterová, Z.; Pichová, I.; Hrušková-Heidingsfeldová, O.

Two SAPP2 gene homologs are present in Candida parapsilosis genome

[rok vydání 2014, impact factor 1.335 ]